Loading…
Patent Eligibility Restoration Act of 2023
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
94pct
215d open
vs 5,649 other S bills in the 118th — cohort avg 33d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (88)
Committee on the Judiciary Subcommittee on Intellectual Property. Hearings held. With printed Hearing: S.Hrg. 118-460.
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2026 · third_quarter · Computer Industry
H.R. 9057 (COOL Online Act), AICOA (American Innovation and Choice Online Act), NO FAKES Act, AI Package, KOSA (Kids Online Safety Act), NDAA FRAND Amendment, USF Reform, Section 230 Reform, PADRA, AI Preemption, AI Voluntary Commitments, Commercial Space Policy, Spectrum Policy. Kids online safety/privacy, HR 633 Patent Reform, Artificial Intelligence, Content Moderation, Digital Replicas, Privacy, Section 230, Digital Trade Barriers, Export Controls, DMA, S 278 Kids Off Social Media Act S. 2220 Prevail act, S 4533 Restore Act, S 2140 Patent Eligibility Restoration Act, S 281 TICKET Act, S 2114 Foreign Adversary Communications Transparency Act, HR 699 Email Privacy Act, Korea's Platform Regulation Bill, immigration reform, Australia Platform Regulation Bill, Artificial Intelligence, Protection Americans from Foreign Backdoor Act, Universal Service Fund, Congressional Review Act, biosecurity, Federal Preemption of state technology laws
Client expense: $90,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR)
2026 · third_quarter · Copyright/Patent/Trademark
Copyright and Patent Reform, Copyright enforcement, Copyright Modernization, Intermediary Liability, Section 301, IPR, RAIA, S2891, WIPO, Music Licensing, Prevail Act S2220, S1409, NO FAKES Act, S1409, generative AI, PADRA, S2140 Patent Eligibility Restoration Act,
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office
2026 · third_quarter · Copyright/Patent/Trademark
I've lobbied in opposition to creating a presumption of irreparable harm in patent litigation under the RESTORE Patent Rights Act of 2025 (S.708, H.R.1574), against weakening the Patent Trial and Appeal Board through administrative or legislative action (e.g., the PREVAIL Act, H.R.4370, S.2220, S.1553), and against the expansion of patent eligibility in the Patent Eligibility Restoration Act (S.2140, H.R.9474, S.1546). I have also supported disclosure of third-party litigation funding (e.g., H.R.1109 and S.3826). I have also supported limitations on foreign entities that represent a national security risk obtaining and enforcing U.S. patents (e.g., H.R.9142, the Prohibiting Adversarial Patents Act).
Client expense: Not reported · Firm income: $110,000
Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, White House Office
2026 · second_quarter · Copyright/Patent/Trademark
H.R. 1574: RESTORE PATENT RIGHTS ACT OF 2025; PROVISIONS RELATED TO INTELLECTUAL PROPERTY AND STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM S. 708: RESTORE PATENT RIGHTS ACT OF 2025; PROVISIONS RELATED TO INTELLECTUAL PROPERTY AND STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM S. 2220 (118TH CONGRESS): PREVAIL ACT; PROVISIONS RELATED TO INTELLECTUAL PROPERTY AND STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM S. 2140 (118TH CONGRESS): PATENT ELIGIBILITY RESTORATION ACT OF 2023; PROVISIONS RELATED TO INTELLECTUAL PROPERTY AND STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM
Client expense: $850,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
2026 · second_quarter · Computer Industry
H.R. 9057 (COOL Online Act), AICOA (American Innovation and Choice Online Act), NO FAKES Act, AI Package, KOSA (Kids Online Safety Act), NDAA FRAND Amendment, USF Reform, Section 230 Reform, PADRA, AI Preemption, AI Voluntary Commitments, Commercial Space Policy, Spectrum Policy. Kids online safety/privacy, HR 633 Patent Reform, Artificial Intelligence, Content Moderation, Digital Replicas, Privacy, Section 230, Digital Trade Barriers, Export Controls, DMA, S 278 Kids Off Social Media Act S. 2220 Prevail act, S 4533 Restore Act, S 2140 Patent Eligibility Restoration Act, S 281 TICKET Act, S 2114 Foreign Adversary Communications Transparency Act, HR 699 Email Privacy Act, Korea's Platform Regulation Bill, immigration reform, Australia Platform Regulation Bill, Artificial Intelligence, Protection Americans from Foreign Backdoor Act, Universal Service Fund, Congressional Review Act
Client expense: $80,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR)
2026 · second_quarter · Copyright/Patent/Trademark
Copyright and Patent Reform, Copyright enforcement, Copyright Modernization, Intermediary Liability, Section 301, IPR, RAIA, S2891, WIPO, Music Licensing, Prevail Act S2220, S1409, NO FAKES Act, S1409, generative AI, PADRA, S2140 Patent Eligibility Restoration Act,
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office
2026 · second_quarter · Copyright/Patent/Trademark
I've lobbied in opposition to creating a presumption of irreparable harm in patent litigation under the RESTORE Patent Rights Act of 2025 (S.708, H.R.1574), against weakening the Patent Trial and Appeal Board through administrative or legislative action (e.g., the PREVAIL Act, H.R.4370, S.2220, S.1553), and against the expansion of patent eligibility in the Patent Eligibility Restoration Act (S.2140, H.R.9474, S.1546). I have also supported disclosure of third-party litigation funding (e.g., H.R.1109 and S.3826).
Client expense: Not reported · Firm income: $110,000
Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Patent & Trademark Office (PTO), SENATE, White House Office
2026 · first_quarter · Copyright/Patent/Trademark
H.R. 1574: RESTORE PATENT RIGHTS ACT OF 2025; PROVISIONS RELATED TO INTELLECTUAL PROPERTY AND STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM S. 708: RESTORE PATENT RIGHTS ACT OF 2025; PROVISIONS RELATED TO INTELLECTUAL PROPERTY AND STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM S. 2220 (118TH CONGRESS): PREVAIL ACT; PROVISIONS RELATED TO INTELLECTUAL PROPERTY AND STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM S. 2140 (118TH CONGRESS): PATENT ELIGIBILITY RESTORATION ACT OF 2023; PROVISIONS RELATED TO INTELLECTUAL PROPERTY AND STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM
Client expense: $1,210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
2026 · first_quarter · Copyright/Patent/Trademark
Copyright and Patent Reform, Copyright enforcement, Copyright Modernization, Intermediary Liability, Section 301, IPR, RAIA, S2891, WIPO, Music Licensing, Prevail Act S2220, S1409, NO FAKES Act, S1409, generative AI, PADRA, S2140 Patent Eligibility Restoration Act,
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office
2026 · first_quarter · Computer Industry
Kids online safety/privacy, HR 633 TAKE IT DOWN Act, HR 8187, Intimate Privacy Protection Act, Patent Reform, Artificial Intelligence, Content Moderation, Digital Replicas, Privacy, Section 230, Digital Trade Barriers, Privacy Working Group, space and spectrum policy, S 4875 No Fakes Act, Export Controls, DMA, S 278 Kids Off Social Media Act S. 2220 Prevail act, S 4533 Restore Act, S 2140 Patent Eligibility Restoration Act, S 281 TICKET Act, S 2114 Foreign Adversary Communications Transparency Act, HR 699 Email Privacy Act, Korea's Platform Regulation Bill, immigration reform, Australia Platform Regulation Bill, Artificial Intelligence, Protection Americans from Foreign Backdoor Act, Universal Service Fund, Congressional Review Act
Client expense: $130,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR)
2025 · fourth_quarter · Computer Industry
Kids online safety/privacy, HR 633 TAKE IT DOWN Act, HR 8187, Intimate Privacy Protection Act, Patent Reform, Artificial Intelligence, Content Moderation, Digital Replicas, Privacy, Section 230, Digital Trade Barriers, Privacy Working Group, space and spectrum policy, S 4875 No Fakes Act, Export Controls, DMA, S 278 Kids Off Social Media Act S. 2220 Prevail act, S 4533 Restore Act, S 2140 Patent Eligibility Restoration Act, S 281 TICKET Act, S 2114 Foreign Adversary Communications Transparency Act, HR 699 Email Privacy Act, Korea's Platform Regulation Bill, immigration reform, Australia Platform Regulation Bill, Artificial Intelligence, Protection Americans from Foreign Backdoor Act, Universal Service Fund, Congressional Review Act
Client expense: $100,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR)
2025 · fourth_quarter · Copyright/Patent/Trademark
Copyright and Patent Reform, Copyright enforcement, Copyright Modernization, Intermediary Liability, Section 301, IPR, RAIA, S2891, WIPO, Music Licensing, Prevail Act S2220, S1409, NO FAKES Act, S1409, generative AI, PADRA, S2140 Patent Eligibility Restoration Act,
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office
2025 · fourth_quarter · Consumer Issues/Safety/Products
REPAIR Act - H.R. 1566/S. 1379 INFORM Consumers Act SHOP Safe Act - S. 2934 S.2140 - Patent Eligibility Restoration Act (PERA) S. 2220 - The PREVAIL Act She Drives Act (S.161)
Client expense: $1,553,187 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2025 · third_quarter · Copyright/Patent/Trademark
H.R. 1574: RESTORE PATENT RIGHTS ACT OF 2025; PROVISIONS RELATED TO INTELLECTUAL PROPERTY, STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM, AND STANDARD ESSENTAL PATENTS (SEPs) S. 708: RESTORE PATENT RIGHTS ACT OF 2025; PROVISIONS RELATED TO INTELLECTUAL PROPERTY, STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM, AND STANDARD ESSENTAL PATENTS (SEPs) S. 2140 (118th CONGRESS): PATENT ELIGIBILITY RESTORATION ACT OF 2023; PROVISIONS RELATED TO INTELLECTUAL PROPERTY, STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM, AND STANDARD ESSENTAL PATENTS (SEPs) S. 2220 (118TH CONGRESS): PREVAIL ACT; PROVISIONS RELATED TO INTELLECTUAL PROPERTY, STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM, AND STANDARD ESSENTAL PATENTS (SEPs)
Client expense: $950,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
2025 · third_quarter · Computer Industry
Kids online safety/privacy, HR 633 TAKE IT DOWN Act, HR 8187, Intimate Privacy Protection Act, Patent Reform, Artificial Intelligence, Content Moderation, Digital Replicas, Privacy, Section 230, Digital Trade Barriers, Privacy Working Group, space and spectrum policy, S 4875 No Fakes Act, Export Controls, DMA, S 278 Kids Off Social Media Act S. 2220 Prevail act, S 4533 Restore Act, S 2140 Patent Eligibility Restoration Act, S 281 TICKET Act, S 2114 Foreign Adversary Communications Transparency Act, HR 699 Email Privacy Act, Korea's Platform Regulation Bill, immigration reform, Australia Platform Regulation Bill, Artificial Intelligence, Protection Americans from Foreign Backdoor Act, Universal Service Fund, Congressional Review Act
Client expense: $70,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR)
2025 · third_quarter · Copyright/Patent/Trademark
Copyright and Patent Reform, Copyright enforcement, Copyright Modernization, Intermediary Liability, Section 301, IPR, RAIA, S2891, WIPO, Music Licensing, Prevail Act S2220, S1409, NO FAKES Act, S1409, generative AI, PADRA, S2140 Patent Eligibility Restoration Act,
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office
2025 · first_quarter · Copyright/Patent/Trademark
General advocacy in support of pro-IP/innovation policies S. 2220, H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2140 - Patent Eligibility Restoration Act (PERA) Opposition to misuse of March-in provisions under the Bayh-Dole Act ITC - IP-related issues S. 2934, H.R. 8684 - SHOP Safe Act Injunctive relief for patent rights holders S. 4840, H.R. 9221 - The RESTORE Patent Rights ACT of 2024 S.4713 - The IDEA Act S.2780 - The Medication Affordability and Patent Integrity Act Proposed Changes to Standard Essential Patent (SEPs) Policies H.R. 9474 Patent Restoration Act (PERA) of 2024 S. 527, Prescription Pricing for the People Act of 2025 S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S. 1097, Interagency Patent Coordination and Improvement Act of 2025
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Consumer Issues/Safety/Products
REPAIR Act - H.R. 1566/S. 1379 INFORM Consumers Act SHOP Safe Act - S. 2934 S.2140 - Patent Eligibility Restoration Act (PERA) S. 2220 - The PREVAIL Act She Drives Act (S.161)
Client expense: $1,618,086 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2025 · second_quarter · Copyright/Patent/Trademark
General advocacy in support of pro-IP/innovation policies S. 2220, H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2140, H.R. 9474 - Patent Eligibility Restoration Act (PERA) Opposition to misuse of March-in provisions under the Bayh-Dole Act ITC - IP-related issues Injunctive relief for patent rights holders S. 4840, H.R. 9221 - The RESTORE Patent Rights ACT of 2024 S.2780 - The Medication Affordability and Patent Integrity Act Proposed Changes to Standard Essential Patent (SEPs) Policies S. 527, Prescription Pricing for the People Act of 2025 S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S. 1097, Interagency Patent Coordination and Improvement Act of 2025 S.1367, H.R. 2794, No Fakes Act
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Copyright/Patent/Trademark
General advocacy in support of pro-IP/innovation policies S. 2220, H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2140, H.R. 9474 - Patent Eligibility Restoration Act (PERA) Opposition to misuse of March-in provisions under the Bayh-Dole Act ITC - IP-related issues Injunctive relief for patent rights holders S. 4840, H.R. 9221 - The RESTORE Patent Rights ACT of 2024 S.2780 - The Medication Affordability and Patent Integrity Act Proposed Changes to Standard Essential Patent (SEPs) Policies S. 527, Prescription Pricing for the People Act of 2025 S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S. 1097, Interagency Patent Coordination and Improvement Act of 2025 S.1367, H.R. 2794, No Fakes Act S. 1095. The Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act S. 2276/H.R. 3269 Eliminating Thickets to Increase Competition Act (Ethics Act)
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
H.R. 1, the One Big, Beautiful Bill Act H.R. 2433, Reducing Medically Unnecessary Delays in Care Act of 2025 Improving seniors' timely access to care act (S. 1816 / H.R. 3514) Genomic Data Protection Act Tariffs S. 998, Medical Supply Chain Resiliency Act S 106 / HR 539 - Chiropractic Medicare Coverage Modernization Act PAMA reform HR 2483, Support for Patients and Communities Reauth Act HR 2484, Seniors access to Critical medications act Reducing Hereditary Cancer Act S 1399, the Health Tech Investment Act H.R. 3580, the Oversight of Medicare Billing Code Cost Act S 1830 - the Right to Treat Act S 1811 - Prohibits Graduate medical schools from receiving Federal assistance if DEI policies are in place S. 1916 - Protect Genetic information after bankruptcy S 1830 - HHS has no authority to regulate the practice of medicine S 2066, Medicare transaction Fraud prevention act LCD legislation S 1866 - National Breast and Cervical Cancer Early Detection Program S 1882 - to expand research and training on reproductive health conditions HR2389/S1302 - Resident Physician Shortage Reduction Act S2333 - Public Health Workforce Loan Repayment Act Health Workforce Resilience Act S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act CLIA Waiver CURES 2.0 To prevent across-the-board direct spending cuts Cytotechnologist labor rates Remote digital telepathology S 1000/HR 2377 SALSA HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs. HR 1202/S 704 - REDI Act HR2761/S 705 - SPARC Act HR 2764/S1229 - Green New Deal for Health HR 3248 - Diagnostic Lab Testing Transparency Act H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023 Student loan repayment for FPs HR 4527 - HEALTH DATA Act Primary Care and Health Workforce Expansion Act S 1994 Counting Veterans Cancer Act HR 4875 Doctors in our Borders Act HR 2474 - Strengthening Medicare for Patients and Providers Act Continuing Appropriations Act, 2024 and Other Extensions Act Further Continuing Appropriations and Other Extensions Act, 2024 HR 6683 - Preserving Seniors Access to Physicians Act of 2023 Gene Therapy Precision Medicine Answers for Kids Today Act S.3018/H.R.3173 the Improving Seniors Timely Access to Care Act of 2021 Dr. Lorna Breen Health Care Provider Protection Act PREVAIL HR 6371 - budget neutrality bill EDUCATE Act - Murphy DEI Bill HR 2369 - VALID Act FDA final rule on LDTs Pandemic All-Hazards Preparedness Act H.R.9747, the Continuing Appropriations and Extensions Act, 2025 S.2140/H.R. 9474, the Patent Eligibility Restoration Act of 2023 S.1451 / H.R. 3120 - Healthy Competition for Better Care Act H.R. 9572 - Enhanced Enforcement of Health Coverage Act H.R. 6025/S. 3211 - Healthcare Workforce Resilience Act Cures 2.1 H.R. 10073, Medicare patient Access and Practice Stabilization Act of 2024 S. 4935, Physician Fee Stabilization Act H.R. 5392, The Timely Access to Coverage Decisions Act of 2023 Medical Lab Personnel Shortage Relief Act H.R. 9572 Enhanced Enforcement of Health Coverage Act Sickle Cell Disease Comprehensive Care Act S. 709/H.R. 1585 - Conrad State 30 and Physician Access Reauthorization Act S. 1380 - SPARC Act S. 942/H.R. 2028 - REDI Act H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025 H.R. 1463 - To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes. H.R. 1968 - Continuing Resolution H.R. 1201 - Doctors in our Borders Act Issues relating to regulation of laboratory diagnostics Patent Eligibility Restoration Act CDC Division of Cancer Prevention and Control and cancer registries appropriations S. 2439 and H.R. 4731, Resident Physician Shortage Reduction Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 HR 3164 - Ensuring Community Access to Pharmacy Services Act (ECAPS) S 2800 - Pharmacy and Medically Underserved Areas Enhancement Act S 2420 / H.R. 4710 - No Surprises Act Enforcement Act S 2793 - Ensuring Access to Essential Providers Act of 2025 H.R. 5582 / S 2355 - Patients Deserve Price Tags Act Issues related to tariffs Issues related to public health
Client expense: $124,816 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Copyright/Patent/Trademark
S2220 the Prevail Act; S2140 Patent Eligibility Restoration Act
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2025 · second_quarter · Copyright/Patent/Trademark
H.R. 1574: RESTORE PATENT RIGHTS ACT OF 2025; PROVISIONS RELATED TO INTELLECTUAL PROPERTY, STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM, AND STANDARD ESSENTAL PATENTS (SEPs) S. 708: RESTORE PATENT RIGHTS ACT OF 2025; PROVISIONS RELATED TO INTELLECTUAL PROPERTY, STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM, AND STANDARD ESSENTAL PATENTS (SEPs) S. 2140 (118th CONGRESS): PATENT ELIGIBILITY RESTORATION ACT OF 2023; PROVISIONS RELATED TO INTELLECTUAL PROPERTY, STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM, AND STANDARD ESSENTAL PATENTS (SEPs) S. 2220 (118TH CONGRESS): PREVAIL ACT; PROVISIONS RELATED TO INTELLECTUAL PROPERTY, STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM, AND STANDARD ESSENTAL PATENTS (SEPs) GENERAL DISCUSSIONS RELATED TO INTELLECTUAL PROPERTY
Client expense: $700,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
2025 · second_quarter · Computer Industry
S 5379 TRAIN Act, Kids online safety/privacy, HR 633 TAKE IT DOWN Act, HR 8187, Intimate Privacy Protection Act, Patent Reform, Artificial Intelligence, Content Moderation, Digital Replicas, Privacy, Section 230, Digital Trade Barriers, Tmobile/UScellular Transaction, Privacy Working Group, space and spectrum policy, S 4875 No Fakes Act, Export Controls, DMA, S 278 Kids Off Social Media Act S. 2220 Prevail act, S 4533 Restore Act, S 2140 Patent Eligibility Restoration Act, S 281 TICKET Act, S 2114 Foreign Adversary Communications Transparency Act, HR 699 Email Privacy Act, Korea's Platform Regulation Bill, immigration reform,
Client expense: $80,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR)
2025 · second_quarter · Copyright/Patent/Trademark
Copyright and Patent Reform, Copyright enforcement, Copyright Modernization, Intermediary Liability, Section 301, IPR, RAIA, S2891, WIPO, Music Licensing, Prevail Act S2220, S1409, NO FAKES Act, S1409, generative AI, PADRA, S2140 Patent Eligibility Restoration Act,
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office
2025 · second_quarter · Copyright/Patent/Trademark
General advocacy in support of pro-IP/innovation policies S. 2220, H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2140, H.R. 9474 - Patent Eligibility Restoration Act (PERA) Opposition to misuse of March-in provisions under the Bayh-Dole Act ITC - IP-related issues Injunctive relief for patent rights holders S. 4840, H.R. 9221 - The RESTORE Patent Rights ACT of 2024 S.2780 - The Medication Affordability and Patent Integrity Act Proposed Changes to Standard Essential Patent (SEPs) Policies S. 527, Prescription Pricing for the People Act of 2025 S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S. 1097, Interagency Patent Coordination and Improvement Act of 2025 S.1367, H.R. 2794, No Fakes Act
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Copyright/Patent/Trademark
S. 2220, the Prevail Act, S. 2140 Patent Eligibility Restoration Act;
Client expense: Not reported · Firm income: $30,000
Government targets: SENATE
2025 · second_quarter · Health Issues
H.R. 1, the One Big, Beautiful Bill Act H.R. 2433, Reducing Medically Unnecessary Delays in Care Act of 2025 Seniors timely access to care act (S. 1816 / H.R. 3514) Genomic Data Protection Act Tariffs S. 998, Medical Supply Chain Resiliency Act S 106 / HR 539 - Chiropractic Medicare Coverage Modernization Act PAMA reform HR 2483, Support for Patients and Communities Reauth Act HR 2484, Seniors access to Critical medications act Reducing Hereditary Cancer Act S 1399, the Health Tech Investment Act H.R. 3580, the Oversight of Medicare Billing Code Cost Act S 1830 - the Right to Treat Act S 1811 - Prohibits Graduate medical schools from receiving Federal assistance if DEI policies are in place S. 1916 - Protect Genetic information after bankruptcy S 1830 - HHS has no authority to regulate the practice of medicine S 2066, Medicare transaction Fraud prevention act LCD legislation S 1866 - National Breast and Cervical Cancer Early Detection Program S 1882 - to expand research and training on reproductive health conditions HR2389/S1302 - Resident Physician Shortage Reduction Act S2333 - Public Health Workforce Loan Repayment Act Health Workforce Resilience Act S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act CLIA Waiver CURES 2.0 To prevent across-the-board direct spending cuts Cytotechnologist labor rates Remote digital telepathology S 1000/HR 2377 SALSA HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs. HR 1202/S 704 - REDI Act HR2761/S 705 - SPARC Act HR 2764/S1229 - Green New Deal for Health HR 3248 - Diagnostic Lab Testing Transparency Act H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023 Student loan repayment for FPs HR 4527 - HEALTH DATA Act Primary Care and Health Workforce Expansion Act S 1994 Counting Veterans Cancer Act HR 4875 Doctors in our Borders Act HR 2474 - Strengthening Medicare for Patients and Providers Act Continuing Appropriations Act, 2024 and Other Extensions Act Further Continuing Appropriations and Other Extensions Act, 2024 HR 6683 - Preserving Seniors Access to Physicians Act of 2023 Gene Therapy Precision Medicine Answers for Kids Today Act S.3018/H.R.3173 the Improving Seniors Timely Access to Care Act of 2021 Dr. Lorna Breen Health Care Provider Protection Act PREVAIL HR 6371 - budget neutrality bill EDUCATE Act - Murphy DEI Bill HR 2369 - VALID Act FDA final rule on LDTs Pandemic All-Hazards Preparedness Act H.R.9747, the Continuing Appropriations and Extensions Act, 2025 S.2140/H.R. 9474, the Patent Eligibility Restoration Act of 2023 S.1451 / H.R. 3120 - Healthy Competition for Better Care Act H.R. 9572 - Enhanced Enforcement of Health Coverage Act H.R. 6025/S. 3211 - Healthcare Workforce Resilience Act Cures 2.1 H.R. 10073, Medicare patient Access and Practice Stabilization Act of 2024 S. 4935, Physician Fee Stabilization Act H.R. 5392, The Timely Access to Coverage Decisions Act of 2023 Medical Lab Personnel Shortage Relief Act H.R. 9572 Enhanced Enforcement of Health Coverage Act Sickle Cell Disease Comprehensive Care Act S. 709/H.R. 1585 - Conrad State 30 and Physician Access Reauthorization Act S. 1380 - SPARC Act S. 942/H.R. 2028 - REDI Act H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025 H.R. 1463 - To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes. H.R. 1968 - Continuing Resolution H.R. 1201 - Doctors in our Borders Act Issues relating to regulation of laboratory diagnostics Patent Eligibility Restoration Act
Client expense: $149,447 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Consumer Issues/Safety/Products
REPAIR Act - H.R. 1566/S. 1379 INFORM Consumers Act SHOP Safe Act - S. 2934 S.2140 - Patent Eligibility Restoration Act (PERA) S. 2220 - The PREVAIL Act She Drives Act (S.161)
Client expense: $1,943,852 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2025 · first_quarter · Copyright/Patent/Trademark
H.R. 4370 Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) H.R. ___ Improving Efficiency to Increase Competition Act (IEICA) H.R.5475 - Prohibiting Adversarial Patents Act of 2023 (PAPA) H.R.9221 - RESTORE Patent Rights Act of 2024 S. ____ - Inventor Diversity for Economic Advancement (IDEA) Act S. 2220 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. __ - Patent Eligibility Reform Act S.1956 - Invent Here, Make Here Act of 2023 S.2140 - Patent Eligibility Restoration Act of 2023 S.4840 - RESTORE Patent Rights Act of 2024 -- regarding policy issues affecting higher education institutions and their faculty and students
Client expense: $70,413 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Copyright/Patent/Trademark
H.R. 1574: RESTORE PATENT RIGHTS ACT OF 2025; PROVISIONS RELATED TO INTELLECTUAL PROPERTY AND STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM S. 708: RESTORE PATENT RIGHTS ACT OF 2025; PROVISIONS RELATED TO INTELLECTUAL PROPERTY AND STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM S. 2140 (118th CONGRESS): PATENT ELIGIBILITY RESTORATION ACT OF 2023; PROVISIONS RELATED TO INTELLECTUAL PROPERTY AND STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM S. 2220 (118TH CONGRESS): PREVAIL ACT; PROVISIONS RELATED TO INTELLECTUAL PROPERTY AND STRENGTHENING THE COPY RIGHT AND PATENT SYSTEM GENERAL DISCUSSIONS RELATED TO INTELLECTUAL PROPERTY
Client expense: $840,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
2025 · first_quarter · Copyright/Patent/Trademark
General advocacy in support of pro-IP/innovation policies S. 2220, H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2140 - Patent Eligibility Restoration Act (PERA) Opposition to misuse of March-in provisions under the Bayh-Dole Act ITC - IP-related issues S. 2934, H.R. 8684 - SHOP Safe Act Injunctive relief for patent rights holders S. 4840, H.R. 9221 - The RESTORE Patent Rights ACT of 2024 S.4713 - The IDEA Act S.2780 - The Medication Affordability and Patent Integrity Act Proposed Changes to Standard Essential Patent (SEPs) Policies H.R. 9474 Patent Restoration Act (PERA) of 2024 S. 527, Prescription Pricing for the People Act of 2025 S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S. 1097, Interagency Patent Coordination and Improvement Act of 2025
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Consumer Issues/Safety/Products
REPAIR Act - H.R. 1566 INFORM Consumers Act SHOP Safe Act - S. 2934 S.2140 - Patent Eligibility Restoration Act (PERA) S. 2220 - The PREVAIL Act She Drives Act (S.161) Issues related to motor vehicle right to repair (House, Senate)
Client expense: $1,235,360 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2025 · first_quarter · Copyright/Patent/Trademark
Issues relating to legislation regarding patents; H.R. 4370/ S. 2220 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (118th Congress); S. 2140 - Patent Eligibility Restoration Act (118th Congress); H.R. 9221/ S. 4840 - RESTORE Patent Rights Act of 2024 (118th Congress).
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Copyright/Patent/Trademark
H.R. 4370 Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) H.R. ___ Improving Efficiency to Increase Competition Act (IEICA) H.R.5475 - Prohibiting Adversarial Patents Act of 2023 (PAPA) H.R.9221 - RESTORE Patent Rights Act of 2024 S. ____ - Inventor Diversity for Economic Advancement (IDEA) Act S. 2220 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. __ - Patent Eligibility Reform Act S.1956 - Invent Here, Make Here Act of 2023 S.2140 - Patent Eligibility Restoration Act of 2023 S.4840 - RESTORE Patent Rights Act of 2024 -- regarding policy issues affecting higher education institutions and their faculty and students
Client expense: $75,967 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Copyright/Patent/Trademark
Patent quality issues and preserving the Patent Trial and Appeal Board (PTAB) - In the 118th Congress bills were S. 2220, HR 4370, the PREVAIL Act; S. 2140 the Patent Eligibility Restoration Act of 2023
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Copyright/Patent/Trademark
Patent quality issues and preserving the Patent Trial and Appeal Board (PTAB) - In the 118th Congress bills were S. 2220, HR 4370, the PREVAIL Act; S. 2140 the Patent Eligibility Restoration Act of 2023
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Copyright/Patent/Trademark
S. 2140: Patent Eligibility Restoration Act of 2023: Provisions regarding Section 2(b)(1)(B)(i) and Section 2(b)(1)(B)(ii), which exclude most inventions implemented in software from patent eligibility as these inventions are not patent ineligible in other countries. S. 2220: Promoting and Respecting Economically Vital American Innovation Leadership Act of 2023 (PREVAIL ACT): Seeking an amendment to balance incentives within the Patent Trial and Appeal Board (PTAB). HR 8132: Balancing Incentives Act of 2024: Issues regarding patents and intellectual property.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Computer Industry
S 5379 TRAIN Act, Kids online safety/privacy, HR 633 TAKE IT DOWN Act, HR 8187, Intimate Privacy Protection Act, Patent Reform, Artificial Intelligence, Content Moderation, Digital Replicas, Privacy, Section 230, Digital Trade Barriers, Tmobile/UScellular Transaction, Privacy Working Group, space and spectrum policy, S 4875 No Fakes Act, Export Controls, DMA, S 278 Kids Off Social Media Act S. 2220 Prevail act, S 4533 Restore Act, S 2140 Patent Eligibility Restoration Act, S 281 TICKET Act, S 2114 Foreign Adversary Communications Transparency Act, HR 699 Email Privacy Act, Korea's Platform Regulation Bill, immigration reform,
Client expense: $80,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Trade Representative (USTR)
2025 · first_quarter · Copyright/Patent/Trademark
Copyright and Patent Reform, Copyright enforcement, Copyright Modernization, Intermediary Liability, Section 301, IPR, RAIA, S2891, WIPO, Music Licensing, Prevail Act S2220, S1409, NO FAKES Act, S1409, generative AI, PADRA, S2140 Patent Eligibility Restoration Act,
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office
2025 · first_quarter · Health Issues
HR2389/S1302 - Resident Physician Shortage Reduction Act S2333 - Public Health Workforce Loan Repayment Act Health Workforce Resilience Act S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act CLIA Waiver CURES 2.0 To prevent across-the-board direct spending cuts Cytotechnologist labor rates Remote digital telepathology S 1000/HR 2377 SALSA HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs. HR 1202/S 704 - REDI Act HR2761/S 705 - SPARC Act HR 2764/S1229 - Green New Deal for Health HR 3248 - Diagnostic Lab Testing Transparency Act H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023 Student loan repayment for FPs HR 4527 - HEALTH DATA Act Primary Care and Health Workforce Expansion Act S 1994 Counting Veterans Cancer Act HR 4875 Doctors in our Borders Act HR 2474 - Strengthening Medicare for Patients and Providers Act Continuing Appropriations Act, 2024 and Other Extensions Act Further Continuing Appropriations and Other Extensions Act, 2024 HR 6683 - Preserving Seniors Access to Physicians Act of 2023 Gene Therapy Precision Medicine Answers for Kids Today Act S.3018/H.R.3173 the Improving Seniors Timely Access to Care Act of 2021 Dr. Lorna Breen Health Care Provider Protection Act PREVAIL HR 6371 - budget neutrality bill EDUCATE Act - Murphy DEI Bill HR 2369 - VALID Act FDA final rule on LDTs Pandemic All-Hazards Preparedness Act H.R.9747, the Continuing Appropriations and Extensions Act, 2025 S.2140/H.R. 9474, the Patent Eligibility Restoration Act of 2023 S.1451 / H.R. 3120 - Healthy Competition for Better Care Act H.R. 9572 - Enhanced Enforcement of Health Coverage Act H.R. 6025/S. 3211 - Healthcare Workforce Resilience Act Cures 2.1 H.R. 10073, Medicare patient Access and Practice Stabilization Act of 2024 S. 4935, Physician Fee Stabilization Act H.R. 5392, The Timely Access to Coverage Decisions Act of 2023 Medical Lab Personnel Shortage Relief Act H.R. 9572 Enhanced Enforcement of Health Coverage Act Sickle Cell Disease Comprehensive Care Act S. 709/H.R. 1585 - Conrad State 30 and Physician Access Reauthorization Act S. 1380 - SPARC Act S. 942/H.R. 2028 - REDI Act H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025 H.R. 1463 - To prohibit the use of Federal funds to implement, administer, or enforce a final rule of the Food and Drug Administration relating to "Medical Devices; Laboratory Developed Tests", and for other purposes. H.R. 1968 - Continuing Resolution H.R. 1201 - Doctors in our Borders Act Issues relating to regulation of laboratory diagnostics Patent Eligibility Restoration Act
Client expense: $217,588 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Copyright/Patent/Trademark
Issues related to the rules governing the Patent Trial and Appeals Board, including both legislative and regulatory proposals. PREVAIL Act, S.2220 (2023). Patent Eligibility Restoration Act, S. 2140 (2023). General opposition to legislative efforts to weaken the Patent Trial & Appeal Board at the USPTO.
Client expense: Not reported · Firm income: $20,000
Government targets: SENATE
2025 · first_quarter · Computer Industry
S. 2220, the Prevail Act, S. 2140 Patent Eligibility Restoration Act;
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Copyright/Patent/Trademark
Issues related to patent quality, Inter Partes Review, and the Patent Trial and Appeal Board (PTAB). Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (S. 2220 and HR 4370 (in the 118th Congress); Patent Eligibility Restoration Act, S. 2140 and HR 9474 (in the 118th Congress); RESTORE Patent Rights Act of 2024, S. 4840 and HR 9221 (in the 118th Congress).
Client expense: Not reported · Firm income: Not reported
2024 · third_quarter · Copyright/Patent/Trademark
Generic Carveouts Patent Protected Information in Drug Labels Including Issues Related to GSK v. Teva. H.R.4370/S.2220: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. S.2140/H.R.9474: Patent Eligibility Restoration Act. H.R.6986/S.3583: To address patent thickets. H.R.5429/S.2780: Medication Affordability and Patent Integrity Act. H.R.9070/S.150: Affordable Prescriptions for Patients Act. S.142: Preserve Access to Affordable Generics and Biosimilars Act. S.4878: The Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. H.R.8134: Restoring Americas Leadership In Innovation Act of 2024. H.R.9221/S.4840: Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive (RESTORE) Patent Rights Act of 2024.
Client expense: $530,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Copyright/Patent/Trademark
Software copyright and related policy issues. Software patents and related policy issues. S. 2220, Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. S. 2934,SHOP SAFE Act. S. 2140, Patent Eligibility Restoration Act of 2023.
Client expense: Not reported · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE, U.S. Copyright Office
2024 · fourth_quarter · Copyright/Patent/Trademark
Patent abuse issues. S. 150 Affordable Prescriptions for Patients Act of 2023. S. 79 Interagency Patent Coordination Act. S. 2780 Medication Affordability and Patent Integrity Act S. 142 Preserve Access to Affordable Generics and Biosimilars Act Joint USPTO-FDA Collaboration Initiatives. S. 2140/H.R.9474 Patent Eligibility Restoration Act of 2023 S. 2220/H.R.4370 PREVAIL Act S. 3583 A bill to address patent thickets. H.R. 6986 To address patent thickets. S.5573 A bill to amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Copyright/Patent/Trademark
S.2140: Patent Eligibility Restoration Act of 2023
Client expense: Not reported · Firm income: $70,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Small Business
Tax Relief and Reform Tax Cuts and Jobs Act of 2017: Support extending/making permanent the expiring provisions of the legislation that terminate in 2025 and have expressed opposition to raising taxes on small businesses. Submitted comments to the House Ways and Means Tax Working group detailing the benefits of the TCJA and our support for permanency. R&D Tax Credit-Immediate Expensing: Continue to support restoring and making permanent full expensing for R&D expenditures for small businesses. Support "American Innovation and Jobs Act" (S. 866) in the Senate and "American Innovation and R&D Competitiveness Act" (H.R. 2673) in the House. Main Street Tax Certainty Act of 2023 (S. 1706, H.R. 4721): Support House and Senate versions of the legislation to make permanent the 20-percent deduction for small businesses (Section 199A). Death Tax Repeal Act of 2023 (S. 1108): Support House and Senate bills to permanently repeal the death tax and continue to support action by Congress. Regulation Basel III Endgame Implementation: Continue to express concern about the proposal by the U.S. Federal Reserve and Federal Deposit and Insurance Corporation in regard to the impact on small business capital access and affordability. Save Local Businesses Act (S.1261, HR 2826): Continue to support the legislation. Protecting the Right to Organize (PRO) Act (S. 567): Continue to oppose the legislation. The Protect Small Business and Prevent Illicit Financial Activity Act: SBE Council supports S. 3625 to delay implementation of the Corporate Transparency Act and H.R. 9278, legislation to delay the Corporate Transparency Acts year-end compliance deadline. We have also supported repeal of this measure via the "Repeal Big Brother Overreach Act." Consumer Financial Protection Bureaus (CFPBs) Rule Capping Credit-Card Late Fees: Continue to voice concern about the rules unintended consequences for small businesses. Prove-It Act (H.R. 7198): Supported House passage of the legislation. Midnight Rules Relief Act (H.R. 115): Supported House passage of the legislation. The Credit Card Competition Act (S.1838): Continue to oppose the legislation. Railway Safety Act (S. 576): SBE Council continues to express concern about the legislation as well as proposals to intrusively regulate the railroad industry, which is dominated by small businesses. The Small Business Regulatory Reduction Act (H.R. 3995): Continue to support full House passage. The Fishery Improvement to Streamline Untimely Regulatory Hurdles post Emergency Situation Act (FISHES Act): Supported House passage of the legislation. Warehouse Worker Protection Act (S.4260): Opposed the introduction of legislation in the U.S. Senate. DOLs Overtime Rule: Requested Wage and Hour Division to delay implementation of the second increase to the minimum salary threshold as mandated by the Final Rule from January 1, 2025 to at least May 1, 2025 pending judicial review, which was currently underway. Federal Trade Commission: SBE Council commented on the Reopening of Solicitation for Public Comments on Provisions of Franchise Agreements and Franchisor Business Practices {Docket No: FTC-2023-0026) because of its one-size-fits-all approach and that it has been pursued and advanced without empirical data or the required cost-benefit analysis. Moreover, reopening the rule in the hopes of acquiring more anecdote to justify it does not address its primary flaws. Federal Deposit Insurance Corporation: SBE Council submitted comments outlining the unnecessary actions proposed by the Change in Bank Control Act proposal (RIN 3064-AG04). Blacklisting: Expressed opposition to the unrelated blacklisting provision in the Workforce Innovation and Opportunity Act (WIOA). Privacy Policy: Continue to express the need for a national regulatory framework, but for Congress to consider a framework that avoids adding to the growing patchwork burden of state privacy laws, and to carefully consider unintended consequences on small businesses. Access to Capital Expanding Access to Capital Act (H.R. 2799): SBE Council supported House passage and action by the U.S. Senate. Affordable Health Coverage and Health Care Innovation Continue to voice ongoing concerns about the rising costs of health coverage and lack of choices in many markets. Voiced support for these various reforms: enhancing tax credits for small businesses, expanding and making additional fixes to HSAs, reforming QSEHRAs, and making CARESs Act telehealth provisions permanent. CHOICE Arrangement Act (H.R. 2799): Supported House passage and continue to support Senate action on the legislation. Tax Credit for Small Businesses: Support making reforms to the restrictive and temporary health care tax credit for small businesses to make it more practical for small businesses. HSA Modernization Act (H.R. 5687) and Bipartisan HSA Improvement Act (H.R. 5688): Continue to support full House action. Telehealth Expansion Act of 2023 (H.R. 1843) (S. 1001): Continue to support full House and Senate action. Telehealth: Joined allies in urging the Centers for Medicare and Medicaid Services (CMS) to expedite the creation of permanent policy related to telehealth practitioners and requirements related to the reporting of their location at the time of service. Chronic Disease Flexible Coverage Act (H.R. 3800): Supported full House passage and Senate action. Paperwork Burden Reduction Act (H.R. 3797): Supported full House passage and Senate action. Employer Reporting Improvement Act (H.R. 3801): Supported full House passage and Senate action. Small Business Flexibility Act (H.R. 3798): Support full House passage. Custom Health Option and Individual Care Expense Arrangement Act (H.R. 3799): Support full House passage. SMART Prices Act (S. 1264): Continue to oppose the legislation. Property Rights and IP March-In and the Bayh Dole Act: Continue to express opposition to a regulatory guidance proposal via the National Institutes of Health (NIST) that considers price as a basis for invalidating the patents of research and innovations seeded with federal government dollars. Patent Eligibility Restoration Act (S.2140): Support the legislation. Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL Act) (S.2220): Support the legislation. Trade and Global Market Access Digital Trade Principles: Continue to express concern about the U.S. pulling away from these global principles and the need for President Biden to revisit the United State Trade Representatives action to withdraw from for foundational positions on digital trade policy within the World Trade Organization (WTO). Supporting Business Competitiveness and Startup Activity Comprehensive Resources for Entrepreneurs in the Arts to Transform the Economy (CREATE) Act (S.3759): Support the legislation. Small Business Technological Advancement Act (S.2330/H.R. 10269): SBE Council supports the legislation. Access to Broadband and Next Gen Technology Rural Internet Improvement Act of 2023 (S.130) (H.R. 3216): Continue to support the legislation. Development of a National Spectrum Strategy (NSS): Continue to express support for such a policy and the need for more spectrum to deploy next Gen technologies and 5G. Nominations National Labor Relations Board Nomination (NLRB): SBE Council opposed the nomination and Senate confirmation of Lauren McFerran to serve another term as Chair of the NLRB.
Client expense: $10,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
2024 · fourth_quarter · Copyright/Patent/Trademark
S. 2220 / H.R. 4370, PREVAIL Act S.2140, Patent Eligibility Restoration Act Issues related to copyright and AI H.R. 10550, The Preventing Abuse of Digital Replicas Act (PADRA) S. 4875, NO FAKES Act of 2024
Client expense: $917,059 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office